What Artrum Treats: Main Uses and Benefits

Artrum is used to provide symptomatic relief across multiple domains of physical discomfort related to musculoskeletal and joint issues. It is applied when patients experience aches and pain, swelling, and stiffness that can interfere with daily functioning. Supportive management is aimed at easing symptomatic discomfort.

This medication is generally used to help with symptoms in conditions characterized by periods of heightened symptoms, such as acute flare-ups of joint discomfort or episodes where pain and stiffness become temporarily disruptive.

It is relevant in clinical settings where short-term symptomatic assistance is needed to help patients cope more steadily. The overall therapeutic benefit is that it helps improve day-to-day comfort during symptomatic periods and supports patients during episodes of heightened discomfort.

---

Quick Facts: Therapeutic Support

• Symptom relief: Used for managing symptoms related to inflammatory or irritative states.
• Targeted Use: Applied when symptoms interfere with daily functioning and supportive relief is appropriate.

Regulatory References

1. NIH MedlinePlus overview on Rheumatoid arthritis

Population Eligibility Profile (Official Regulatory Data)

Regulatory agencies define the authorized use of Artrum (Ketoprofen) through specific contraindications and conditional restrictions based on health status and age.

Absolute Contraindications (Must Not Use)

The medicine is strictly prohibited for patients with a documented hypersensitivity to ketoprofen or any excipients, and for those who have experienced asthma or allergic reactions to aspirin or other Non-steroidal Anti-inflammatory Drugs (NSAIDs).

Use is contraindicated in the setting of Coronary Artery Bypass Graft (CABG) surgery, during the third trimester of pregnancy (from 30 weeks gestation), and for patients with severe heart failure, active peptic ulcer disease, or severe hepatic/renal impairment.

Restricted and Conditional Use

Use in the pediatric population (under 18 years for prescription use) is not established due to insufficient data on safety and effectiveness. Use is permitted in older adults but requires caution and close monitoring due to increased risks. For patients with mild-to-moderate renal or hepatic impairment, use is permitted only under specified dosage limitations and close functional monitoring.

Artrum is generally not recommended for women who are breastfeeding or those attempting to conceive.

Artrum Interactions with other medicines and products

The interaction profile for Artrum (ketoprofen) is documented through several pharmacokinetic and pharmacodynamic interaction patterns identified in government regulatory labeling. This profile outlines specific restrictions on co-administration with other medicines, supplements, and clinical conditions.

Interaction Classification	Interacting Agents	Officially Documented Effect
Contraindicated	Other NSAIDs, High-dose Salicylates	Increased risk of serious GI adverse events.
Prohibited Procedure	Peri-operative pain in CABG Surgery	Formal restriction prohibiting use in this setting.
Exposure Modification	Methotrexate, Lithium, Probenecid	Ketoprofen decreases the renal clearance of Methotrexate and Lithium, leading to increased plasma concentrations. Probenecid co-administration is documented to increase ketoprofen exposure.
Pharmacodynamic Risk	Anticoagulants, Antiplatelets, SSRIs, Oral Corticosteroids	Additive risk of hemorrhage and serious gastrointestinal bleeding.

Ketoprofen may diminish the therapeutic effects of certain medicines. Co-administration with Angiotensin-Converting Enzyme (ACE) inhibitors, Angiotensin II Receptor Blockers (ARBs), and diuretics may reduce their intended antihypertensive or diuretic action. This combination also increases the risk of renal function decline, a risk documented as being greater in elderly patients and those with existing renal impairment. Chronic, daily consumption of alcohol is documented as significantly increasing the risk of serious gastrointestinal events. Herbal products that inhibit platelet function (e.g., ginkgo) also carry an increased bleeding risk. Regulatory documents formally note that ketoprofen does not induce drug-metabolizing enzymes.

How Artrum Works: The Mechanistic Blueprint

The mechanism of Artrum is achieved through the dual modulation of the prostaglandin synthesis pathway and subsequent effects on the body's nociceptive and thermoregulatory signaling systems. The mechanism is derived exclusively from its active ingredient, ketoprofen, a non-selective inhibitor of cyclooxygenase (COX) enzymes.

---

Inhibition of Prostaglandin Synthesis

This action involves the reversible, non-selective inhibition of the COX-1 and COX-2 enzymes. By interrupting the Arachidonic Acid Cascade, the molecule blocks the conversion of arachidonic acid into pro-inflammatory mediators, primarily PGE2. This modification of the humoral signaling pathway restricts the physiological effects of vasodilation and increased vascular permeability at the local tissue level.

Modulation of Nociceptive and Thermoregulatory Signaling

The reduced PGE2 levels lead to two distinct physiological effects: they decrease the sensitization of peripheral nociceptors (pain receptors) to injury-related chemical triggers, and they permit the readjustment of the hypothalamic thermal set point. These molecular actions translate to a reduced transmission of nociceptive signals and increased heat dissipation, respectively, influencing central and peripheral systems.

The administration of Artrum (ketoprofen) is structured around its route of administration, dosing schedule, and contextual intake conditions. The medicine is available for oral administration using immediate-release (IR) or extended-release (ER) forms, and for topical application as a gel.

For systemic use, the IR formulation utilizes a divided dose schedule, such as 50 mg four times daily or 75 mg three times daily, with a maximum daily limit of 300 mg. The ER formulation is administered once daily at 200 mg, although it is not recommended for acute pain. All treatment should adhere to the principle of using the lowest effective dose for the shortest possible duration. Topical use typically involves applying the gel two to four times daily, usually for a duration not exceeding one week.

Procedurally, oral doses may be taken with food, milk, or antacids to ease administration, and ER forms must be swallowed whole. If a scheduled dose is missed, it is generally advised to skip the missed dose and resume the regular timing, without taking a double dose. Special dose adjustments are utilized for specific patient groups: older adults require a reduced starting dose, and patients with renal or hepatic impairment have lower maximum daily limits.

Research Evidence: Overview of Studies for Artrum (Ketoprofen)

This section summarizes the types of research and the study populations used in the clinical evaluation of Artrum, strictly adhering to what studies were conducted and what patterns the evidence describes.

---

Evidence for Use in Chronic Joint Conditions (RA and OA)

Research was studied for conditions characterized by fluctuating or episodic manifestations, such as rheumatoid arthritis (RA) and osteoarthritis (OA). This evaluation primarily relies on randomized controlled trials (RCTs) and systematic reviews, which compile data from multiple studies. These studies were generally conducted during periods of increased symptom activity and monitored adult patients to examine whether changes occurred in patient-reported outcomes describing perceived discomfort and outcomes reflecting daily functioning or activity level.

In these trials, researchers monitored symptom intensity, such as pain scores and stiffness, over defined time intervals of a few weeks up to three months. The findings describe patterns observed in the studies where patients receiving the medicine reported various measured outcomes related to physical discomfort and function compared to those who received an inactive placebo.

Evidence for Use in Acute, Short-Term Pain Relief

Artrum was studied for acute, disruptive episodes of pain, such as those arising from musculoskeletal injuries or dental procedures. For these uses, the research typically involved short-term, single-dose, controlled clinical trials. These studies were designed to assess immediate symptomatic responses, measuring outcomes describing episodic or acute changes.

In these defined research scenarios, studies monitored how quickly a measurable change in pain intensity was observed in the populations and how long the effect lasted. The findings help contextualize how patients reported their experience of symptomatic change shortly after administration.

---

What is Still Uncertain About Artrum Research

While the research contributes to the broader evidence landscape regarding how Artrum was studied for different types of pain and inflammation, several areas of uncertainty remain. Evidence quality varies across studies, and the findings, particularly in chronic conditions, are often limited by the short follow-up durations. The evidence contributes to understanding short-term symptom patterns; however, data are still emerging regarding long-term outcomes related to daily functioning. This highlights what is known—and what is still uncertain—about the medicine's use in settings with varying symptom burdens.

Key Studies & References

1. Ketoprofen 2.5% gel: a clinical overview
2. Ketoprofen - LiverTox (NIH) - LiverTox - Clinical and Research Information on Drug-Induced Liver Injury

Common questions about Artrum (FAQ)

---

Q: How long does it take for Artrum to start working for acute pain?

Studies and official information indicate that Artrum was researched for acute, disruptive episodes of pain. Clinical trials for acute pain were designed to assess immediate symptomatic responses. The findings describe how quickly patients in those studies reported a measurable change in their pain experience shortly after the administration of a single dose.

---

Q: What is the recommended dose of Artrum for chronic pain?

Regulatory documents describe the immediate-release (IR) and extended-release (ER) forms. The ER formulation is typically administered once daily and is noted as not being suitable for acute pain. All treatment, regardless of the formulation used, must follow the principle of using the lowest effective dose for the shortest possible duration.

---

Q: Is Artrum safe to take if I am pregnant?

According to the official product information, Artrum is strictly contraindicated (meaning it must not be used) during the third trimester of pregnancy, which starts at 30 weeks gestation. For the first and second trimesters, regulatory information indicates that the drug should only be used when the potential benefit to the patient is considered to outweigh the potential risk to the developing fetus.

---

Q: Does Artrum interact with cold and flu medicine?

Official labeling notes that Artrum is strictly contraindicated for co-administration with other non-steroidal anti-inflammatory drugs (NSAIDs) and high-dose salicylates. The potential for interaction with specific cold and flu medicines depends on whether those products contain other NSAIDs or agents documented to interact with Artrum.

---

Q: Can a child take Artrum for a fever?

Official regulatory data specifies that the use of prescription Artrum in the pediatric population (those under 18 years old) is generally not established. This is due to insufficient data regarding its safety and effectiveness in this specific age group.

---

Q: Are there any dietary restrictions while taking Artrum?

Official instructions advise that the oral forms of Artrum may be taken with food, milk, or antacids to help ease administration. However, regulatory documents formally note that chronic, daily consumption of alcohol is linked to a significantly increased risk of serious gastrointestinal events.

Official Storage and Disposal Instructions

Official regulatory documents define the required storage and disposal profile for all medicinal products, including Artrum, to ensure stability and public safety.

Storage Conditions

Requirement	Official Regulatory Statement
Temperature & Protection	Store Artrum strictly within the specific temperature range stated on the product label. Keep the medication in its original container to protect it from moisture, light, or other environmental factors that may compromise its stability.
Child Safety	As a mandatory requirement for all medicines, Artrum must be stored in a secure location, out of the sight and reach of children.
In-Use Stability	If applicable (e.g., after opening or reconstitution), adhere to the official shelf-life period defined in the product information, and discard the product after this period.

Disposal Rules

Requirement	Official Regulatory Statement
Disposal Method	Unused or expired Artrum should be returned to an authorized drug take-back program or pharmacy for proper disposal, as recommended by government health agencies. Do not dispose of it in household trash or flush it unless specifically instructed by official labeling, ensuring compliance with environmental regulations.